CVA Family Office’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12
Closed -$1.22K 1853
2025
Q4
$1.22K Hold
12
﹤0.01% 1070
2025
Q3
$657 Hold
12
﹤0.01% 1194
2025
Q2
$638 Hold
12
﹤0.01% 1173
2025
Q1
$519 Hold
12
﹤0.01% 1253
2024
Q4
$674 Hold
12
﹤0.01% 1159
2024
Q3
$817 Hold
12
﹤0.01% 1105
2024
Q2
$507 Buy
+12
New +$660 ﹤0.01% 1200
2022
Q1
Sell
-10
Closed -$1K 961
2021
Q4
$1K Buy
+10
New +$883 ﹤0.01% 874

Other funds holding EXAS

CVA Family Office's EXAS Position: Q1 2026 in Review

CVA Family Office sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12 shares — an estimated $1.22K sold.

CVA Family Office first reported a position in EXAS in Q4 2021 and held it in 8 quarters. The position peaked at $1.22K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • CVA Family Office reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • CVA Family Office sold 12 Exact Sciences shares in Q1 2026, an estimated $1.22K.
  • CVA Family Office first reported a position in Exact Sciences in Q4 2021 and held it in 8 quarters.
  • CVA Family Office's Exact Sciences position peaked at $1.22K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.